CEL-SCI Co. (CVM) to Release Quarterly Earnings on Tuesday
CEL-SCI (NYSEMKT:CVM) last issued its quarterly earnings data on Wednesday, May 10th. The company reported ($0.05) EPS for the quarter. CEL-SCI had a negative return on equity of 4,970.98% and a negative net margin of 48,949.30%. The business had revenue of $0.02 million during the quarter. On average, analysts expect CEL-SCI to post $-0.4200 EPS for the current fiscal year and $-0.2900 EPS for the next fiscal year.
CEL-SCI Co. (CVM) opened at 2.3691 on Monday. The stock’s market capitalization is $21.78 million. The firm has a 50 day moving average of $2.03 and a 200-day moving average of $0.59. CEL-SCI Co. has a 52 week low of $1.46 and a 52 week high of $13.55.
CEL-SCI Company Profile
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.
Receive News & Stock Ratings for CEL-SCI Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI Co. and related stocks with our FREE daily email newsletter.